Guardant Health (GH) Interest Expenses (2017 - 2026)

Guardant Health has reported Interest Expenses for 10 years, with the latest figure at $416.4 million in Q2 2026.

• Quarterly Interest Expenses rose 42258.49% year-over-year to $416.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $416.4 million (up 19984.62% YoY) and the FY2025 annual result came in at $788.8 million, up 13.26% from the prior year.
• Interest Expenses grew to $416.4 million in Q2 2026 per GH's latest filing, from $261.1 million in the prior quarter.
• Over five years, Interest Expenses peaked at $416.4 million in Q2 2026 and troughed at -$1.9 million in Q4 2024.
• A 5-year average of $128.8 million and a median of $1.1 million in 2024 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2023 and 2026: Interest Expenses slumped 400.16% in 2023, then surged 42258.49% in 2026.
• Over 5 years, Interest Expenses stood at $644000.0 in 2022, then plunged by 400.16% to -$1.9 million in 2023, then dropped by 0.1% to -$1.9 million in 2024, then surged by 154.47% to $1.1 million in 2025, then surged by 39405.12% to $416.4 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $416.4 million, $261.1 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.